On Wednesday, Halozyme Therapeutics, Inc. (HALO) stock saw a decline, ending the day at $53.46 which represents a decrease of $-0.36 or -0.67% from the prior close of $53.82. The stock opened at ...
On Monday, Halozyme Therapeutics, Inc. (HALO) stock saw a modest uptick, ending the day at $53.95 which represents a slight increase of $0.95 or 1.79% from the prior close of $53. The stock opened at ...